Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

By I. Thompson, D. Pauler, P. Goodman, C. Tangen, M. Lucia, H. Parnes, L. Minasian, L. Ford, S. Lippman, E. Crawford and 2 more. New England Journal of Medicine, 2004

2,581 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/1412c68455fe3b4d48df27766c20a1ae8df5c44d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. A. Heidenreich
2. Michel Bolla
3. N. Mottet
4. J. Bellmunt
5. V. Matveev
6. Steven Joniau
7. Thomas Wiegel

Citations in the corpus

• EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. (2011, result): “The finding that many men may harbour PCa, despite low levels of serum PSA, has been underscored by recent results from a US prevention study [17] (LE: 2a).”
• Autoantibody signatures in prostate cancer. (2005, neutral): “Circled spots represent five phage-peptide clones: 5'-UTR_BMI1 (1), eIF4G1 (2), RPL13a (3), BRD2 (4), and RPL22 (5).”